Literature DB >> 28871620

Oropharyngeal surfactant can improve initial stabilisation and reduce rescue intubation in infants born below 25 weeks of gestation.

Tereza Lamberska1, Eva Settelmayerova1, Jan Smisek1, Marketa Luksova1, Gabriela Maloskova1, Richard Plavka1.   

Abstract

AIM: Minimally aggressive and easily performed techniques that facilitate spontaneous respiratory stabilisation are required to reduce rescue intubation in extremely premature infants. This study evaluated the feasibility and safety of administering surfactant into the pharynx of infants born at <25 weeks immediately after birth.
METHODS: This study of 19 infants was conducted from January 2013 to June 2014 in a tertiary perinatal centre in Prague. We administered 1.5 mL of Curosurf as a bolus into the pharynx and simultaneously performed a sustained inflation manoeuvre (SIM). The extent of the interventions, death and severe neonatal morbidity in the study group were compared with 20 controls born before the study period and 20 born after it.
RESULTS: All infants received oropharyngeal surfactant within the median (interquartile range) time of 40 seconds (25-75) after cord camping. The surfactant had to be suctioned in one infant because of upper airway obstruction. Although more subsequent surfactant was administered in the study group, significantly fewer study period infants required intubation than the before and after controls (16% versus 75% and 58%, respectively, p < 0.01).
CONCLUSION: Oropharyngeal surfactant with simultaneous SIM was feasible and safe and reduced the need for delivery room intubation in these fragile infants. ©2017 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Delivery room intubation; Oropharyngeal surfactant; Rescue intratracheal intubation; Threshold of viability

Mesh:

Substances:

Year:  2017        PMID: 28871620     DOI: 10.1111/apa.14060

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

Review 1.  Surfactant replacement therapy: from biological basis to current clinical practice.

Authors:  Roland Hentschel; Kajsa Bohlin; Anton van Kaam; Hans Fuchs; Olivier Danhaive
Journal:  Pediatr Res       Date:  2020-01-11       Impact factor: 3.756

2.  Study protocol for the POPART study-Prophylactic Oropharyngeal surfactant for Preterm infants: A Randomised Trial.

Authors:  Madeleine Claire Murphy; Marie Galligan; Brenda Molloy; Rabia Hussain; Peter Doran; Colm O'Donnell
Journal:  BMJ Open       Date:  2020-07-20       Impact factor: 2.692

3.  Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art.

Authors:  Ömer Erdeve; Emel Okulu; Kari D Roberts; Scott O Guthrie; Prem Fort; H Gözde Kanmaz Kutman; Peter A Dargaville
Journal:  Turk Arch Pediatr       Date:  2021-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.